Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

9.05
Delayed Data
As of 4:00pm ET
 +0.33 / +3.78%
Today’s Change
7.00
Today|||52-Week Range
13.20
-29.95%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close8.72
Today’s open8.77
Day’s range8.56 - 9.09
Volume147,945
Average volume (3 months)214,976
Market cap$331.5M
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+71.52%
Earnings growth (this year)-74.84%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.02+0.34%
CRVSCorvus Pharmaceutica...+0.25+1.54%
CLSDClearside Biomedical...+0.85+5.15%
KPTIKaryopharm Therapeut...+0.28+2.96%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$1.08
Annual revenue (last year)$0.00
Annual profit (last year)-$60.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
John P. Butler
CFO, Treasure, SVP &
Principal Accounting Officer
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs